Follow the 大参林 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 大参林 has logged 1 insider filings. Market capitalisation: €21.6bn. The latest transaction was reported on 16 August 2023 (Sale). Among the most active insiders: 陈洪. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
大参林 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the distribution of pharmaceutical and healthcare products.